pidotimod has been researched along with ovalbumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avolio, M; Becker, PD; Caruso, A; Fiorentini, S; Giagulli, C; Guzman, CA; Noerder, M | 1 |
| Fu, AK; Fu, LQ; Hu, SL; Li, WF; Li, YL; Wang, YY; Wu, YP | 1 |
2 other study(ies) available for pidotimod and ovalbumin
| Article | Year |
|---|---|
Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antigens, CD; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Cytotoxicity, Immunologic; Dendritic Cells; Female; HLA-DR Antigens; Humans; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Nasal Mucosa; Ovalbumin; Peptide Fragments; Pyrrolidonecarboxylic Acid; Th1 Cells; Thiazolidines; Tumor Necrosis Factor-alpha | 2009 |
Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
Topics: Animals; Arginase; Asthma; Bronchoalveolar Lavage Fluid; Cell Differentiation; Disease Models, Animal; Down-Regulation; Eosinophils; Female; Hypersensitivity; Immunoglobulin E; Intercellular Signaling Peptides and Proteins; Lung; Metaplasia; Mice, Inbred C57BL; Mucus; Ovalbumin; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Th2 Cells; Thiazolidines | 2017 |